Extracorporal shock wave therapy enhances receptor for advanced glycated end-product-dependent flap survival and angiogenesis

Background/ObjectivesLoss of skin flaps due to deteriorated wound healing is a crucial clinical issue. Extracorporal shock wave therapy (ESWT) promotes flap healing by inducing angiogenesis and suppressing inflammation. The receptor for advanced glycation end-products (RAGEs) was identified to play

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Birgin, Emrullah (Verfasst von) , Gebhardt, Christoffer (Verfasst von) , Hetjens, Svetlana (Verfasst von) , Fischer, Sebastian (Verfasst von) , Rückert, Felix (Verfasst von) , Reichenberger, Matthias (Verfasst von)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 2018
In: Annals of plastic surgery
Year: 2018, Jahrgang: 80, Heft: 4, Pages: 424-431
ISSN:1536-3708
DOI:10.1097/SAP.0000000000001279
Online-Zugang:Verlag, Volltext: https://doi.org/10.1097/SAP.0000000000001279
Volltext
Verfasserangaben:Emrullah Birgin, Christoffer Gebhardt, Svetlana Hetjens, Sebastian Fischer, Felix Rückert, and Matthias Reichenberger
Beschreibung
Zusammenfassung:Background/ObjectivesLoss of skin flaps due to deteriorated wound healing is a crucial clinical issue. Extracorporal shock wave therapy (ESWT) promotes flap healing by inducing angiogenesis and suppressing inflammation. The receptor for advanced glycation end-products (RAGEs) was identified to play
Beschreibung:Gesehen am 06.09.2019
Beschreibung:Online Resource
ISSN:1536-3708
DOI:10.1097/SAP.0000000000001279